If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Arix Bioscience, Amryt Pharma and Paul Hill on 5 Stocks to Follow
Jonathan Tobin, Managing Director at Arix Bioscience #ARIX and VelosBio Board Director discusses Merck's $2.75 billion acquisition of VelosBio.
Arix Bioscience plc is a global venture capital company focused on investing in and building breakthrough biotech companies around cutting edge advances in life sciences. We collaborate with exceptional entrepreneurs and provide the capital, expertise and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors.
Joe Wiley, CEO of Amryt Pharma #AMYT talks about their record Q3 Results where they've raised FY 2020 revenue guidance.
Amryt is a biopharmaceutical company focused on developing and delivering innovative new treatments to help improve the lives of patients with rare and orphan diseases. Amryt comprises a strong and growing portfolio of commercial and development assets.
(Interview starts at 11 minutes 13 seconds)
Paul Hill, full time investor and equity analyst talks about 5 stock to add to your watchlist including:
Astrazeneca #AZN
GSK #GSK
SourceBio International #SBI
Mpac Group #MPAC
Verici DX #VRCI
Gattaca #GATC
Proactis Holdings #PHD
(Interview starts at 24 minutes 10 seconds)